Prospective Investigator Initiated Study to investigate Efficacy and Safety of cell-free Autologous Conditioned Serum (ACS) in reduced facial skin elasticity by woman - OrthoSkin

niversität HamburgFachrichtung Kosmetikwissenschaft0 个研究点目标入组 21 人开始时间: 2015年12月22日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Provision of signed and dated informed consent form to participate in the study
•2. Non-pregnant, non-breast feeding female aged 35-55 years
•3. Loss of facial skin elasticity according to the Investigator’s opinion
•4.Intent to improve skin structure and the elasticity of the skin using cell-free ACS

•1. Severe skin diseases e.g. psoriasis, atopic eczema (neurodermatitis), acne, active herpes zoster or other autoimmune skin diseases in the face
•2. Skin cancer in the anamnesis
•3. Treatment with chemotherapy, immunosuppressive
•agents or immunomodulatory therapy (e.g. corticosteroids, monoclonal antibodies) within three months before study treatment.
•4. Systemic diseases with skin involvement (SLE)
•5. Pre-treatment with laser, botox or hyaluronic acid in the lower face (treatment areal)
•6. Severe diet in the last 3 months or nutritional
•supplementary during the study duration of 24 week
•7. Acute infection
•8. Pregnancy or woman who plan to become pregnant during the course of the study
•9. History of bleeding disorders or treatment with
•anticoagulants or inhibitors of platelet aggregation (e.g. ASS or other non-steroidal anti-inflammatory drugs [NSAIDs])
•10. Tendency to form keloids, hypertrophic scars or other healing disorder
•11. Any medical history that, in the opinion of the Investigator, would make the subject unsuitable for inclusion (e.g. chronic, relapsing or hereditary disease that may affect the outcome of the study.)

发起方

niversität HamburgFachrichtung Kosmetikwissenschaft